Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

PN Perspectives: The FDA, Social Media and the Future of Health Care Communications

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
152 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 11, 2009

On Tuesday, Nov. 10, 2009 Porter Novelli hosted PN Perspectives: The FDA, Social Media and the Future of Health Care Communications at the Yale Club of New York City to provide healthcare companies a forum in which to better understanding smart, aggressive and FDA-compliant social media communications. A select audience of product marketers, corporate regulatory and legal counsel, and industry communications professionals attended this event for discussions with a panel including the FDA's Julie Zawisza, assistant commissioner for public affairs; Peter Pitts, partner and director, global health at Porter Novelli and president of the Center for Medicine in the Public Interest; and Stephanie Agresta, executive vice president, global director, social media at Porter Novelli.

Peter Pitts also will be testifying at the FDAs Part 15 public hearing on Nov. 12 and 13, 2009 in Washington, D.C., and a separate webcast for the hearing will be available next week. More information on the hearing can be found at edocket.access.gpo.gov/2009/E9-22618.htm.

To request FDA-compliant social media counseling or training for your company or to address related communications questions, please e-mail Peter Pitts at peter.pitts@porternovelli.com, or call 212-601-8208.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more